Meflynate Xl

Methylphenidate Hydrochloride, the active ingredient in Meflynate Xl, is a central nervous system stimulant presented as an oral tablet (strength unspecified) for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults. GNH USA supplies Meflynate Xl as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meflynate Xl is a central nervous system stimulant used in the management of neurodevelopmental and sleep‑wake disorders.

- Attention deficit hyperactivity disorder (children): improves focus, reduces hyperactivity and impulsivity. - Attention deficit hyperactivity disorder (adults): enhances concentration and task performance. - Narcolepsy: decreases excessive daytime sleepiness and cataplexy.

Meflynate Xl may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced food intake, especially in children. - Headache: mild to moderate intensity. - Stomach pain or nausea: gastrointestinal discomfort. - Increased heart rate: mild tachycardia. - Anxiety or nervousness: heightened emotional tension.

Serious or Rare Side Effects: - Hypertension: significant elevation of blood pressure. - Cardiac arrhythmia: irregular heart rhythm. - Psychosis or severe mood changes: hallucinations or aggressive behavior. - Seizures: increased risk in susceptible individuals. - Allergic reactions: rash, swelling, or anaphylaxis. - Priapism: prolonged, painful erection in males.

Before prescribing Meflynate Xl, clinicians should evaluate several safety considerations.

- Cardiovascular assessment: review blood pressure and heart disease history. - Growth monitoring: regularly measure height and weight in pediatric patients. - Psychiatric evaluation: avoid use in patients with severe anxiety or psychosis. - Seizure risk: exercise caution in individuals with a history of seizures. - Concomitant MAO inhibitors: ensure a washout period before starting therapy. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Meflynate Xl can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Sympathomimetic agents: may cause excessive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): potential for increased serotonergic effects. - Antihypertensive drugs: possible reduction in blood pressure control. - Antacids: may alter absorption of the drug. - Seizure threshold‑lowering agents: heightened risk of seizures.